TOLL FREE: 888.88.INFECT
PHONE: 517.536.8210
FAX: 517.536.8205

THE WELLHOFF CENTER
7190 S. BROOKLYN RD.
JACKSON, MI 49201

TransPharm Preclinical Solutions TransPharm Preclinical Solutions TransPharm Preclinical Solutions TransPharm Preclinical Solutions

Urinary Tract Infection

A urinary tract infection, or UTI, is an infection involving any part of the urinary system. Infections are typically limited to the urethra and bladder, but can also spread to the ureters and kidneys. UTIs are some of the most common and problematic of hospital-acquired infections as they are often associated with catheters or stents. Our model of an ascending urinary tract infection is used to determine the efficacy of novel antimicrobial agents and to guide dosing strategies in human patients.

Procedure
We have established a urinary tract infection model in mice in which animals are challenged with an infectious agent via intraurethral injection. Test article may be administered via oral gavage (PO) or intraurethral, subcutaneous (SC), intraperitoneal (IP), or intravenous (IV) injection. The route, duration, and frequency of dosing can be customized to meet client needs. The endpoint for this study is CFU burden in harvested organs and/or blood. Pharmacokinetic profiling, blood chemistry, and histology are available upon request.

Pathogens
TransPharm has validated a urinary tract infection model using the following pathogens:

  • Escherichia coli
    • CFT073
  • Pseudomonas aeruginosa
    • ATCC 27853

Additional validations available upon request.